Revolution Medicines, Inc. Common Stock(RVMD)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

RVMD iron condor setups RVMD expected move RVMD IV rank history RVMD Fibonacci levels

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

RVMD $183.03 —
Snapshot
$183.03
After hours $186.50 +1.90%
52-Week Range
$34.00 – $193.82
YTD
+131.62%
IV Rank (30D)
14.35
Straddle Price
$22.90
P/C Vol Ratio
0.22
Market Cap
$39.0B
Fair Value
MODEL: SHORT

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.55%
Beta vs SPY1.00
Cost of Equity (CAPM)10.05% (VRP-adj)
WACC10.07%
Volatility Risk Premium+21.9pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-1.1B
Return on Equity (TTM)-91.5%
Book / Price4.3%
Debt / Equity0.00
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$165.10 (Market Anchor value)
SMA 20 / Bollinger Mid$184.32
Bollinger Width / SMA207.4% (drives anchor stability)
Net Debt$-0.4B
Market Cap$35B
Peers used for multiples: ABBV, AMGN, GILD, LLY, MRK, NTRA, REGN, VRTX
Model Conviction
27%
20-Day Fair Value
≈ by Aug 20, 2026
$191.69
α +4.7% rank 25%
40-Day Fair Value
≈ by Sep 18, 2026
$181.00
α -1.1% rank 25%
60-Day Fair Value
≈ by Oct 19, 2026
$177.30
α -3.1% rank 25%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 28.1× · 7 peers
Peer EV/EBITDA n/a 0% median 17.9× · 7 peers
Peer P/B $55.06 16% median 7.0× · 7 peers
Peer P/S n/a 0% median 6.3× · 8 peers
Market Anchor (SMA50) $165.10 84% stability 100% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-07-22 · updated
Info
Industry (SIC)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836)
Exchange
XNAS
Market Cap
$39.0B

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic ag…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan +3.11% 6
Feb +0.33% 7
Mar -1.26% 7
Apr +13.81% 7
May -1.74% 7
Jun +4.48% 7
Jul -1.25% 7
Aug +3.82% 6
Sep +1.72% 6
Oct +2.85% 6
Nov +17.58% 6
Dec -1.19% 6
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $185.01
SMA 50: $165.93
SMA 200: $110.55
Current: $183.35
EMA 12: $183.35
EMA 26: $178.17
MACD: 5.1744 | Signal: -1.8435
BULLISH
ADX (14): 34.28
TREND
+DI: 23.88
−DI: 15.96
Momentum Oscillators
RSI (14): 56.70
NEUTRAL
Stoch %K: 35.59
Stoch %D: 37.34
Williams %R: -58.77
Volume & Volatility
BB Upper: $195.54
BB Lower: $174.48
NEUTRAL
OBV: 113,049,176
Vol SMA 20: 2,859,841
Vol ROC: -67.78%
ATR: $6.85
True Range: $5.29
HV 20: 38.2%
HV 30: 38.8%
HV 60: 47.2%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-07-23T00:00:00 – 2026-07-21T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
7 of 8 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-07 After-Close 14.37% 2.41% 0.17x Within
2024-11-06 After-Close 12.13% 1.48% 0.12x Within
2025-02-26 After-Close 10.34% 0.11% 0.01x Within
2025-05-07 After-Close 8.36% 11.63% 1.39x Exceeded
2025-08-06 After-Close 13.96% 2.19% 0.16x Within
2025-11-05 After-Close 10.02% 5.84% 0.58x Within
2026-02-25 After-Close 13.75% 0.29% 0.02x Within
2026-05-06 After-Close 6.65% 5.67% 0.85x Within
Options Activity
IV Rank (30D)
14.35
IV Rank (7D)
14.35
Avg IV
67.2%
Straddle (30D)
$22.90
Straddle (7D)
$22.90
P/C Volume
0.22
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.14
Correlation (SPY)
21.4%
R²
0.05
Ann. Volatility
67.4%
SPY Volatility
12.7%

Above average volatility - stock moves with market amplification

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-06-30
Diluted shares outstanding: 191,510,512 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

540 filers182,427,682 shares$16.76B value95.26% of float
# Filer Shares Value % of Total % of Float Period
1 VANGUARD GROUP INC Custodian 16,719,886 $1.33B 7.95% 8.73% 2025-12-31
2 BlackRock, Inc. Custodian 11,212,706 $1.09B 6.51% 5.85% 2026-03-31
3 JANUS HENDERSON GROUP PLC 9,766,496 $949.54M 5.67% 5.10% 2026-03-31
4 BAKER BROS. ADVISORS LP 9,555,357 $929.26M 5.54% 4.99% 2026-03-31
5 FMR LLC Custodian 8,464,314 $823.15M 4.91% 4.42% 2026-03-31
6 Nextech Invest, Ltd. 7,601,087 $739.21M 4.41% 3.97% 2026-03-31
7 Paradigm Biocapital Advisors LP 6,655,703 $647.27M 3.86% 3.48% 2026-03-31
8 WELLINGTON MANAGEMENT GROUP LLP Custodian 6,027,819 $586.21M 3.50% 3.15% 2026-03-31
9 ADAGE CAPITAL PARTNERS GP, L.L.C. 5,475,611 $532.50M 3.18% 2.86% 2026-03-31
10 STATE STREET CORP 4,402,662 $428.16M 2.55% 2.30% 2026-03-31
11 UBS Group AG Custodian 4,386,791 $426.62M 2.55% 2.29% 2026-03-31
12 GEODE CAPITAL MANAGEMENT, LLC Custodian 3,338,142 $323.93M 1.93% 1.74% 2026-03-31
13 Alphabet Inc. 3,292,525 $320.20M 1.91% 1.72% 2026-03-31
14 BVF INC/IL 2,856,782 $277.82M 1.66% 1.49% 2026-03-31
15 Casdin Capital, LLC 2,577,333 $250.65M 1.50% 1.35% 2026-03-31
16 Woodline Partners LP 2,506,570 $243.76M 1.45% 1.31% 2026-03-31
17 Holocene Advisors, LP 2,468,644 $240.08M 1.43% 1.29% 2026-03-31
18 Vestal Point Capital, LP 2,375,000 $230.97M 1.38% 1.24% 2026-03-31
19 Avoro Capital Advisors LLC 2,344,444 $228.00M 1.36% 1.22% 2026-03-31
20 DEERFIELD MANAGEMENT COMPANY, L.P. 2,297,000 $223.38M 1.33% 1.20% 2026-03-31
21 GOLDMAN SACHS GROUP INC Custodian 2,185,500 $212.54M 1.27% 1.14% 2026-03-31
22 Darwin Global Management, Ltd. 2,211,018 $204.98M 1.22% 1.15% 2026-03-31
23 Logos Global Management LP 2,000,000 $194.50M 1.16% 1.04% 2026-03-31
24 Alyeska Investment Group, L.P. 1,885,821 $183.40M 1.09% 0.98% 2026-03-31
25 NATIONAL BANK OF CANADA /FI/ Custodian 1,749,000 $170.09M 1.01% 0.91% 2026-03-31
19 filers$294.51M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $112.66M 38.26% 2026-03-31
2 Integral Health Asset Management, LLC $48.62M 16.51% 2026-03-31
3 Caption Management, LLC $31.42M 10.67% 2026-03-31
4 CITADEL ADVISORS LLC Custodian $26.73M 9.08% 2026-03-31
5 Caligan Partners LP $22.26M 7.56% 2026-03-31
6 JANE STREET GROUP, LLC Custodian $13.48M 4.58% 2026-03-31
7 Kite Lake Capital Management (UK) LLP $9.72M 3.30% 2026-03-31
8 BOOTHBAY FUND MANAGEMENT, LLC $4.89M 1.66% 2026-03-31
9 BALYASNY ASSET MANAGEMENT L.P. $4.86M 1.65% 2026-03-31
10 TIG Advisors, LLC $4.83M 1.64% 2026-03-31
11 LMR Partners LLP $3.89M 1.32% 2026-03-31
12 Squarepoint Ops LLC $3.34M 1.13% 2026-03-31
13 D. E. Shaw & Co., Inc. Custodian $3.03M 1.03% 2026-03-31
14 PEAK6 LLC $1.98M 0.67% 2026-03-31
15 WOLVERINE TRADING, LLC Custodian $1.23M 0.42% 2025-09-30
16 UBS Group AG Custodian $729.38K 0.25% 2026-03-31
17 CSS LLC/IL $408.45K 0.14% 2026-03-31
18 Greenland Capital Management LP $389.00K 0.13% 2026-03-31
19 SIGNATUREFD, LLC $5.25K <0.01% 2026-03-31
27 filers$481.95M notional
# Filer Notional Value % of Total Period
1 Caption Management, LLC $119.32M 24.76% 2026-03-31
2 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $99.12M 20.57% 2026-03-31
3 Integral Health Asset Management, LLC $72.94M 15.13% 2026-03-31
4 BOOTHBAY FUND MANAGEMENT, LLC $35.19M 7.30% 2026-03-31
5 CITADEL ADVISORS LLC Custodian $32.04M 6.65% 2026-03-31
6 Kynam Capital Management, LP $20.18M 4.19% 2026-03-31
7 JANE STREET GROUP, LLC Custodian $19.25M 3.99% 2026-03-31
8 LMR Partners LLP $16.53M 3.43% 2026-03-31
9 DIADEMA PARTNERS LP $12.20M 2.53% 2026-03-31
10 Affinity Asset Advisors, LLC $9.72M 2.02% 2026-03-31
11 Verition Fund Management LLC $9.72M 2.02% 2026-03-31
12 Ikarian Capital, LLC $9.24M 1.92% 2026-03-31
13 683 Capital Management, LLC $4.87M 1.01% 2026-03-31
14 BALYASNY ASSET MANAGEMENT L.P. $4.86M 1.01% 2026-03-31
15 Hudson Bay Capital Management LP $4.86M 1.01% 2026-03-31
16 Twin Securities, Inc. $3.79M 0.79% 2026-03-31
17 D. E. Shaw & Co., Inc. Custodian $2.43M 0.50% 2026-03-31
18 Diametric Capital, LP $1.46M 0.30% 2026-03-31
19 WOLVERINE TRADING, LLC Custodian $1.42M 0.30% 2025-09-30
20 HARVEST MANAGEMENT LLC $933.60K 0.19% 2026-03-31
21 TIG Advisors, LLC $573.77K 0.12% 2026-03-31
22 STEMPOINT CAPITAL LP $525.00K 0.11% 2026-03-31
23 CSS LLC/IL $301.48K 0.06% 2026-03-31
24 Point72 Asset Management, L.P. $252.85K 0.05% 2026-03-31
25 NINE MASTS CAPITAL Ltd $107.25K 0.02% 2026-03-31
Insider Activity
Latest: 2026-07-01
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-07-01 Sushil Patel Director Mixed −2,625 $135.90 -$938.0K EDGAR
2026-06-26 Jack Anders Chief Financial Officer Mixed — $93.45 -$3.00M EDGAR
2026-06-23 Sushil Patel Director Award (A) +1,191 — EDGAR
2026-06-23 Alexis Borisy Director Award (A) +1,191 — EDGAR
2026-06-23 Flavia Borellini Director Award (A) +1,191 — EDGAR
2026-06-23 Sandra Horning Director Award (A) +1,191 — EDGAR
2026-06-23 Lorence H. Kim Director Award (A) +1,191 — EDGAR
2026-06-23 ELIZABETH M ANDERSON Director Award (A) +1,191 — EDGAR
2026-06-23 Frank Clyburn Director Award (A) +1,191 — EDGAR
2023-11-14 Thilo Schroeder Director Award (A) +1,457,211 — EDGAR
2023-11-14 Alexis Borisy Director Award (A) +2,091,672 — EDGAR
2023-11-14 Sandra Horning Director Award (A) +90,487 — EDGAR
2023-10-25 Margaret A Horn Chief Operating Officer Exer (M) +7,500 $0.54 $4.1K EDGAR
2023-10-24 MARK A GOLDSMITH See Remarks Exer (M) +35,000 $0.49 $17.1K EDGAR
2023-10-23 Jack Anders Chief Financial Officer Exer (M) +24,524 $2.98 $73.0K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
27 insiders · @ $183.35
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Third Rock Ventures III, L.P. 10%+ Owner 8,933,348 $1.64B $0 1 2020-12-04
2 COLUMN GROUP III-A, LP 10%+ Owner 7,977,384 $1.46B $0 1 2020-02-18
3 Ponoi II Management, LLC 10%+ Owner 2,836,037 $519.99M -$664.10M 2 2020-11-18
4 Alexis Borisy Director 2,340,075 $429.05M $0 6 2026-06-23
5 KEVIN P STARR 10%+ Owner 1,909,317 $350.07M $0 1 2020-02-18
6 Thilo Schroeder Director 1,553,134 $284.77M $63.30M 9 2023-11-14
7 Third Rock Ventures IV, L.P. 10%+ Owner 1,419,900 $260.34M $0 1 2020-02-18
8 James E Flynn 10%+ Owner 798,795 $146.46M $61.20M 1 2020-02-18
9 MARK A GOLDSMITH See Remarks 711,879 $130.52M -$11.79M 26 2023-10-24
10 Peter Svennilson Director 705,313 $129.32M -$84.23M 6 2021-04-28
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2026-06-29
Last 30d: 2 filings · $4.4M notice value  ·  Last 90d: 12 filings · $24.6M notice value · 7 unique filers · 92% under 10b5-1 plans

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: MARGARET A HORN (3, $15.8M) · Anders Jack (2, $3.8M) · ANTHONY MANCINI (3, $1.5M) · GOLDSMITH MARK A (1, $1.5M) · SUSHIL PATEL (1, $1.0M)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-06-29 SUSHIL PATEL Director 5,580 $1.02M 2026-06-29 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-06-24 JACK ANDERS Officer 20,000 $3.39M 2026-06-24 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-06-15 Mancini Anthony Officer 4,211 $647.9K 2026-06-15 ETRADE Financial Corporation — EDGAR
2026-06-15 Cislini Jeff Officer 1,656 $254.8K 2026-06-15 ETRADE Financial Corporation 10b5-1 EDGAR
2026-06-15 MARGARET A HORN Officer 90,000 $13.85M 2026-06-15 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-06-15 Anders Jack Officer 2,653 $408.2K 2026-06-15 ETRADE Financial Corporation 10b5-1 EDGAR
2026-06-15 Kelsey Stephen Michael Officer 4,071 $626.4K 2026-06-15 ETRADE Financial Corporation 10b5-1 EDGAR
2026-06-15 Horn Margaret A Officer 3,486 $536.4K 2026-06-15 ETRADE Financial Corporation 10b5-1 EDGAR
2026-06-15 GOLDSMITH MARK A Officer, Director 9,772 $1.50M 2026-06-15 ETRADE Financial Corporation 10b5-1 EDGAR
2026-06-11 MARGARET A HORN Officer 10,000 $1.44M 2026-06-11 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
Recent SEC Filings
Latest: 2026-05-06
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-05-06 0001193125-26-208918 EDGAR
2026-04-17 0001193125-26-161800 EDGAR
2026-04-16 0001193125-26-159289 EDGAR
2026-04-13 0001193125-26-152039 EDGAR
2026-02-25 0001193125-26-071517 EDGAR
2025-11-05 0001193125-25-266836 EDGAR
2025-10-17 0001193125-25-241736 EDGAR
2025-09-10 0001193125-25-200078 EDGAR
2025-08-06 0000950170-25-103983 EDGAR
2025-06-27 0001193125-25-151254 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-25 0001193125-26-071563 EDGAR
2025-02-26 0000950170-25-027736 EDGAR
2024-02-26 0000950170-24-020145 EDGAR
2023-02-27 0000950170-23-004645 EDGAR
2022-02-28 0000950170-22-002297 EDGAR
2021-03-02 0001564590-21-010276 EDGAR
2020-03-30 0001564590-20-014169 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-05-06 0001193125-26-208969 EDGAR
2025-11-05 0001193125-25-266923 EDGAR
2025-08-06 0000950170-25-104022 EDGAR
2025-05-07 0000950170-25-065660 EDGAR
2024-11-06 0000950170-24-122303 EDGAR
2024-08-07 0000950170-24-092783 EDGAR
2024-05-08 0000950170-24-055655 EDGAR
2023-11-06 0000950170-23-059391 EDGAR
2023-08-08 0000950170-23-039805 EDGAR
2023-05-08 0000950170-23-018805 EDGAR
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio25.6
EV/EBITDA-27.5
TTM Net Income$-1.4B
TTM EPS$-7.1
ROE-91.5%